A mutation in the second intracellular loop of the pituitary adenylate cyclase activating polypeptide type I receptor confers constitutive receptor activation

被引:8
作者
Cao, YJ [1 ]
Gimpl, G [1 ]
Fahrenholz, F [1 ]
机构
[1] Univ Mainz, Inst Biochem, D-55099 Mainz, Germany
关键词
pituitary adenylate cyclase activating polypeptide; peptide hormone receptor; site-directed mutagenesis; constitutive activity; cAMP; signal transduction;
D O I
10.1016/S0014-5793(00)01269-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pituitary adenylate cyclase activating polypeptide (PACAP) type I receptor belongs to the glucagon/secretin/ vasoactive intestinal polypeptide (VIP) receptor family. We mutated and deleted an amino acid residue (E261) which is located within the second intracellular loop of the rat PACAP type I receptor and which is highly conserved among the receptor family. The wild-type receptor and the mutant receptors were efficiently expressed at the surface of COS-7 cells at nearly the same level and revealed the same high affinity for the agonist PACAP-27, The cAMP contents of COS cells transfected with the E261A, E261Q, and the deletion mutant receptor mere 4.6-, 5.7-, and 6.7-fold higher as compared with COS cells transfected with the wild-type receptor. Thus, all the mutant PACAP receptors were constitutively active, The data suggest that the glutamic acid in the second intracellular loop of the PACAP receptor may be a key residue to constrain the receptor in the inactive conformation with respect to its coupling to G(s) proteins. (C) 2000 Federation of European Biochemical Societies.
引用
收藏
页码:142 / 146
页数:5
相关论文
共 29 条
[1]   PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) AND ITS RECEPTORS - NEUROENDOCRINE AND ENDOCRINE INTERACTION [J].
ARIMURA, A ;
SHIODA, S .
FRONTIERS IN NEUROENDOCRINOLOGY, 1995, 16 (01) :53-88
[2]   PACAP FUNCTIONS AS A NEUROTROPHIC FACTOR [J].
ARIMURA, A ;
SOMOGYVARIVIGH, A ;
WEILL, C ;
FIORE, RC ;
TATSUNO, I ;
BAY, V ;
BRENNEMAN, DE .
MODELS OF NEUROPEPTIDE ACTION, 1994, 739 :228-243
[3]   PRESENCE OF HIGHLY SELECTIVE RECEPTORS FOR PACAP (PITUITARY ADENYLATE-CYCLASE ACTIVATING PEPTIDE) IN MEMBRANES FROM THE RAT PANCREATIC ACINAR CELL-LINE AR-4-2J [J].
BUSCAIL, L ;
GOURLET, P ;
CAUVIN, A ;
DENEEF, P ;
GOSSEN, D ;
ARIMURA, A ;
MIYATA, A ;
COY, DH ;
ROBBERECHT, P ;
CHRISTOPHE, J .
FEBS LETTERS, 1990, 262 (01) :77-81
[4]   MOLECULAR-STRUCTURE ANALYSIS OF THE PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE TYPE-I RECEPTOR FROM PIG BRAIN [J].
CAO, YJ ;
GIMPL, G ;
FAHRENHOLZ, F .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1994, 1222 (03) :432-440
[5]   Photoaffinity labeling analysis of the interaction of pituitary adenylate-cyclase-activating polypeptide (PACAP) with the PACAP type I receptor [J].
Cao, YJ ;
Kojro, E ;
Gimpl, G ;
Jasionowski, M ;
Kasprzykowski, F ;
Lankiewicz, L ;
Fahrenholz, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 244 (02) :400-406
[6]   THE AMINO-TERMINAL FRAGMENT OF THE ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) RECEPTOR FUNCTIONS AS A HIGH-AFFINITY PACAP FINDING DOMAIN [J].
CAO, YJ ;
GIMPL, G ;
FAHRENHOLZ, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 212 (02) :673-680
[7]   Alterations in receptor activation and divalent cation activation of agonist binding by deletion of intracellular domains of the glucagon receptor [J].
Chicchi, GG ;
Graziano, MP ;
Koch, G ;
Hey, P ;
Sullivan, K ;
Vicario, PP ;
Cascieri, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (12) :7765-7769
[8]   Activation mechanism of human oxytocin receptor: A combined study of experimental and computer-simulated mutagenesis [J].
Fanelli, F ;
Barbier, P ;
Zanchetta, D ;
De Benedetti, PG ;
Chini, B .
MOLECULAR PHARMACOLOGY, 1999, 56 (01) :214-225
[9]   Constitutive activation of the human vasoactive intestinal peptide 1 receptor, a member of the new class II family of G protein-coupled receptors [J].
Gaudin, P ;
Maoret, JJ ;
Couvineau, A ;
Rouyer-Fessard, C ;
Laburthe, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) :4990-4996
[10]   Mutation of Asn(111) in the third transmembrane domain of the AT(1A) angiotensin II receptor induces its constitutive activation [J].
Groblewski, T ;
Maigret, B ;
Larguier, R ;
Lombard, C ;
Bonnafous, JC ;
Marie, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) :1822-1826